| On the practical aspects of large-scale production of 177Lu for peptide receptor radionuclide therapy using direct neutron activation of 176Lu in a medium flux … S Chakraborty, KV Vimalnath, SP Lohar, P Shetty, A Dash Journal of Radioanalytical and Nuclear Chemistry 302, 233-243, 2014 | 51 | 2014 |
| Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles S Chattopadhyay, KV Vimalnath, S Saha, A Korde, HD Sarma, S Pal, ... Applied Radiation and Isotopes 66 (3), 334-339, 2008 | 35 | 2008 |
| Synthesis and Preclinical Evaluation of 177Lu-CHX-A”-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma M Kameswaran, U Pandey, C Dhakan, K Pathak, V Gota, KV Vimalnath, ... Cancer Biotherapy and Radiopharmaceuticals 30 (6), 240-246, 2015 | 31 | 2015 |
| A versatile technique for radiochemical separation of medically useful no-carrier-added (nca) radioarsenic from irradiated germanium oxide targets S Chattopadhyay, S Pal, KV Vimalnath, MK Das Applied Radiation and Isotopes 65 (11), 1202-1207, 2007 | 29 | 2007 |
| Radiosynovectomy of painful synovitis of knee joints due to rheumatoid arthritis by intra-articular administration of 177 Lu-labeled hydroxyapatite particulates: first human … A Shinto, K Kamaleshwaran, S Chakraborty, K Vyshakh, ... World Journal of Nuclear Medicine 14 (02), 81-88, 2015 | 28 | 2015 |
| Prospects of medium specific activity 177Lu in targeted therapy of prostate cancer using 177Lu‐labeled PSMA inhibitor S Chakraborty, R Chakravarty, P Shetty, KV Vimalnath, IB Sen, A Dash Journal of Labelled Compounds and Radiopharmaceuticals 59 (9), 364-371, 2016 | 24 | 2016 |
| Radiolanthanide-loaded agglomerated Fe 3 O 4 nanoparticles for possible use in the treatment of arthritis: formulation, characterization and evaluation in rats S Chakraborty, KS Sharma, A Rajeswari, KV Vimalnath, HD Sarma, ... Journal of materials chemistry B 3 (27), 5455-5466, 2015 | 24 | 2015 |
| Preparation, evaluation, and first clinical use of 177Lu‐labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient … S Chakraborty, KV Vimalnath, A Rajeswari, A Shinto, HD Sarma, ... Journal of Labelled Compounds and Radiopharmaceuticals 57 (7), 453-462, 2014 | 23 | 2014 |
| Tracer level radiochemistry to clinical dose preparation of 177Lu-labeled cyclic RGD peptide dimer S Chakraborty, HD Sarma, KV Vimalnath, MRA Pillai Nuclear Medicine and Biology 40 (7), 946-954, 2013 | 22 | 2013 |
| Development of a dry distillation technology for the production of 131I using medium flux reactor for radiopharmaceutical applications RN Ambade, SN Shinde, MSA Khan, SP Lohar, KV Vimalnath, PV Joshi, ... Journal of Radioanalytical and Nuclear Chemistry 303, 451-467, 2015 | 20 | 2015 |
| Aspects of yield and specific activity of (n,γ) produced 177Lu used in targeted radionuclide therapy KV Vimalnath, P Shetty, SP Lohar, VC Adya, SK Thulasidas, ... Journal of Radioanalytical and Nuclear Chemistry 302, 809-812, 2014 | 19 | 2014 |
| Practicality of production of 32P by direct neutron activation for its utilization in bone pain palliation as Na3 [32P] PO4 KV Vimalnath, P Shetty, S Chakraborty, T Das, V Chirayil, HD Sarma, ... Cancer Biotherapy and Radiopharmaceuticals 28 (5), 423-428, 2013 | 19 | 2013 |
| High purity materials as targets for radioisotope production: Needs and challenges V Shivarudrappa, KV Vimalnath Bulletin of Materials Science 28, 325-330, 2005 | 19 | 2005 |
| Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n, γ) route KV Vimalnath, S Chakraborty, A Rajeswari, HD Sarma, J Nuwad, ... Nuclear Medicine and Biology 42 (5), 455-464, 2015 | 18 | 2015 |
| Multidose formulation of ready-to-use 177Lu-PSMA-617 in a centralized radiopharmacy set-up S Chakraborty, KV Vimalnath, R Chakravarty, HD Sarma, A Dash Applied Radiation and Isotopes 139, 91-97, 2018 | 16 | 2018 |
| One decade of ‘bench-to-bedside’peptide receptor radionuclide therapy with indigenous [177Lu] Lu-DOTATATE obtained through ‘direct’neutron activation route: lessons learnt … S Basu, S Chakraborty, RV Parghane, R Ranade, P Thapa, RV Asopa, ... American Journal of Nuclear Medicine and Molecular Imaging 10 (4), 178, 2020 | 14 | 2020 |
| Prospects and problems in the production of 143Pr for radionuclide therapy applications KV Vimalnath, MK Das, M Venkatesh, N Ramamoorthy Radiochimica Acta 93 (7), 419-426, 2005 | 14 | 2005 |
| 64 CuCl 2 produced by direct neutron activation route as a cost-effective probe for cancer imaging: the journey has begun R Chakravarty, S Chakraborty, KV Vimalnath, P Shetty, HD Sarma, ... RSC advances 5 (111), 91723-91733, 2015 | 13 | 2015 |
| Radiolanthanide-labeled HA particles in the treatment of rheumatoid arthritis: ready-to-use cold kits for rapid formulation in hospital radiopharmacy S Chakraborty, KV Vimalnath, A Rajeswari, HD Sarma, A Shinto, ... Journal of Radioanalytical and Nuclear Chemistry 302, 875-881, 2014 | 13 | 2014 |
| Reactor production of 32P for medical applications: an assessment of 32S(n,p)32P and 31P(n,γ)32P methods KV Vimalnath, P Shetty, A Rajeswari, V Chirayil, S Chakraborty, A Dash Journal of Radioanalytical and Nuclear Chemistry 301, 555-565, 2014 | 13 | 2014 |
